American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
PLEASANTON, Calif., Nov. 14, 2017 -- The Cooper Companies, Inc. (NYSE:COO) will present at the BMO Prescriptions for Success Healthcare Conference in New York, NY, on December 14, 2017. Daniel G. McBride, Esq, Executive Vice President, Chief Operating Officer & President of CooperVision, Inc., will represent the Company in a presentation scheduled to begin at 1:30 PM ET.
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at http://investor.coopercos.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-G
Source: The Cooper Companies, Inc.
CONTACT:
Kim Duncan
Vice President, Investor Relations
[email protected]
